Activist & passive stakes

Investors crossing the 5% ownership line, from SEC Schedule 13D (activist) and 13G (passive) filings. Newest first.

Showing the last 10 days.Sign up free for 90 days
Amendments only.1–9 of 9
  • ActivistAmendment 9
    Nov 11, 2026
    TRIB · Trinity Biotech plc
    Perceptive Advisors LLC
    9.99% · 54,148,590 shSEC
  • PassiveAmendment 3
    Nov 10, 2026
    PPBT · Purple Biotech Ltd.
    Mitchell P. Kopin
    9.99% · 206,941,858 shSEC
  • ActivistAmendment 8
    Nov 6, 2026
    VIR · Vir Biotechnology, Inc.
    Robert Nelsen
    7.3% · 12,508,029 shSEC
  • PassiveAmendment 1Below 5%
    Nov 6, 2026
    LTGO · Latigo Biotherapeutics, Inc.
    AI Biotechnology LLC
    4.8% · 3,193,565 shSEC
  • PassiveAmendment 1
    Nov 6, 2026
    TRAX · First Tracks Biotherapeutics Inc
    Fmr Llc
    15% · 6,302,672 shSEC
  • PassiveAmendment 4
    Nov 5, 2026
    SANA · Sana Biotechnology Inc
    Fmr Llc
    12.5% · 37,293,854 shSEC
  • PassiveAmendment 10
    Nov 5, 2026
    LEGN · Legend Biotech Corp
    Fmr Llc
    12.4% · 48,164,808 shSEC
  • PassiveAmendment 1
    Nov 4, 2026
    EDSA · Edesa Biotech, Inc.
    Millennium Management LLC
    8.7% · 1,178,577 shSEC
  • ActivistAmendment 6Below 5%
    Nov 3, 2026
    NAUT · Nautilus Biotechnology, Inc.
    Perceptive Advisors LLC
    3.9% · 4,944,512 shSEC